Alexion Pharmaceuticals to Report Fourth Quarter and Full Year 2012 Results on Thursday, February 14, 2013

http://pdf.reuters.com/htmlnews/8knews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20130131:nBw315389a

CHESHIRE, Conn.--(Business Wire)--
Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) today announced that the Company
will report its financial results for the fourth quarter and year ended December
31, 2012 on Thursday, February 14, 2013 before the US financial markets open.
Following the release of the financial results, Alexion management will conduct
a conference call and audio web cast on Thursday, February 14, 2013, at 10:00
a.m. Eastern Time (ET).

To participate in this conference call, dial 888-206-4836 (USA) or 913-312-1267
(International), passcode 5044697 shortly before 10:00 a.m. ET. A replay of the
call will be available from 1:00 p.m. ET through a limited time thereafter. The
replay number is 888-203-1112 (USA) or 719-457-0820 (International), passcode
5044697. The audio web cast can be accessed at: www.alexionpharma.com.

[ALXN-G]

Alexion Pharmaceuticals, Inc.
Irving Adler, 203-271-8210
Executive Director, Corporate Communications
or
Media:
Alexion Pharmaceuticals, Inc.
Kim Diamond, 203-439-9600
Director, Corporate Communications
or
Investors:
Rx Communications
Rhonda Chiger, 917-322-2569

Copyright Business Wire 2013